AI assistant
Pacira BioSciences, Inc. — Director's Dealing 2011
Feb 2, 2011
32125_dirs_2011-02-02_a0214da9-17f2-42a3-aeed-14146fe4dae5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2011-02-02
Reporting Person: PATOU GARY (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.61 | 2020-09-02 | Common Stock (59042) | Direct | |
| Stock Option (Right to Buy) | $1.61 | 2020-09-02 | Common Stock (59042) | Direct | |
| Stock Option (Right to Buy) | $5.49 | 2020-12-29 | Common Stock (42368) | Direct |
Footnotes
F1: The option vests as to 50% of the option shares on September 2, 2010 and the remaining 50% of the option shares vests equally monthly over the next 24 months.The option shares become exercisable when vested.
F2: 25% of the option shares vest on September 2, 2011 and the remaining 75% of the option shares shall vest monthly over the next 36 months. The option shares become exercisable when vested.
F3: 25% of the option shares vest on December 29, 2011 and the remaining 75% of the option shares shall vest monthly over the next 36 months. The option shares become exercisable when vested.